Biotech4 years ago
The biotech company Inventiva announced the success of its NASH treatment
The Burgundian biotech company announced on Monday, June 15th, the success on different efficacy criteria of its lanifibranor molecule to treat patients suffering from Non-Alcoholic Steatohepatitis,...